1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow RO6927005: new trials by email Literature Review of RO6927005 trials Research Report on RO6927005
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors RO6927005, gemcitabine, nab-paclitaxel - Cancer | Phase 1 | Terminated | Hoffmann-La Roche | 15 | 2014-12-01 | 2016-07-26 |
Neoplasms (1)
Canada (1) · Denmark (1) · France (1) · United States (1)
2014 (1)